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Neural stem cells (NSCs) and neural progenitor cells (NPCs) are
self-renewing and multipotent cells, however, NPCs are considered
to be more lineage-restricted with a reduced self-renewing capa-
city. We present data comparing the expression of 21 markers
encompassing pluripotency, self-renewal (NSC) as well as neuronal
and glial (astrocyte and oligodendrocyte) lineage speciﬁcation and
28 extracellular proteoglycan (PG) genes and their regulatory
enzymes between embryonic stem cell (ESC)-derived human NSCs
(hNSC H9 cells, Thermo Fisher) and human cortex-derived normal
human NPCs (nhNPCs, Lonza). The data demonstrates expression
differences of multiple lineage and proteoglycan-associated genes
between hNSC H9 cells and nhNPCs. Data interpretation of mar-
kers and proteoglycans deﬁning NSC and neural cell lineage
characterisation can be found in “Cell surface heparan sulfate pro-
teoglycans as novel markers of human neural stem cell fate deter-
mination” (Oikari et al. 2015) [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.scr.2015.12.011
e, Institute of Health and Biomedical Innovation, School of Biomedical
Musk Ave, Kelvin Grove, QLD 4059, Australia.
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Dubject area Cell biology
ore speciﬁc sub-
ject areaHuman neural stem cell (hNSC) and human neural progenitor cell (hNPC)
marker characterisationype of data Text ﬁle, graphs and immunoﬂuorescence images
ow data was
acquiredin vitro culture/expansion and phase-contrast ﬂuorescence microscopy data for
phenotypic analysis was obtained on an Olympus IX81 inverted ﬂuorescent
microscope via Volocity Imaging package; raw Q-PCR data was obtained on
Applied Biosystems 7900HT Fast Real-Time PCR systemata format Analysed
xperimental
factorshNSC H9 and nhNP cells were cultured under basal medium conditionsxperimental
featureshNSC H9 cells (Thermo Fisher) were cultured as a monolayer and nhNP cells
(Lonza) were cultured as neurospheres in standard maintenance medium
provided by the manufacturer. RNA was harvested and transcribed to cDNA and
gene expression of a panel of 49 genes examined by Q-PCR. Speciﬁc neural cell
lineage markers were further detected through immunoﬂuorescence (IF)ata source
locationInstitute of Health and Biomedical Innovation, Queensland University of Tech-
nology, Brisbane, Queensland Australiaata accessibility Data is provided in this articleD
 The data provides an extensive panel of markers for better characterisation of human NSCs and NPCs.
 The data demonstrates signiﬁcant and speciﬁc differences in expression of pluripotency, NSC self-
renewal and neural cell lineage markers between hNSCs and hNPCs.
 The marker proﬁle data could be used to identify and differentiate between the two cell types to
improve their efﬁcacy in research or therapeutic applications.
 The data provides information on the proteoglycan proﬁle of human NSCs and NPCs providing
potential new additional markers deﬁning lineage progression of NSCs to NPCs.1. Data
We compared the expression of 49 selected genes between human NSCs (hESC-derived hNSC H9 cells,
Thermo Fisher) and normal human progenitor cells (nhNPCs, Lonza) following short-term culture under
basal growth conditions. Q-PCR data was obtained for pluripotency genes, NSC, neuronal, astrocyte and
oligodendrocyte lineage deﬁning genes (n¼21; Table 1.) (Fig. 1) with several of these markers also detected
through immunoﬂuorescence (IF) (Fig. 2) using speciﬁc antibodies (Table 3). In addition, Q-PCR data was
obtained for 28 heparan and chondroitin sulphate proteoglycan biosynthesis enzymes and core protein
genes (Table 2) ubiquitous to the neural niche [1–7] in hNSC H9 cells and nhNPCs (Figs. 3 and 4). The data
presented provides information on self-renewal and multilineage potential as well as proteoglycan
expression differences between the two neural stem/progenitor cell types.2. Experimental design, materials and methods
2.1. Cell culture
Gibcos human neural stem cells derived from NIH-approved H9 (WA09) embryonic stem cells (hNSC
H9 cells) were cultured as a monolayer on Geltrexs coated culture dishes in StemPros NSC serum-free
medium (NSC SFM) containing KnockOUT™ DMEM/F-12 supplemented with 2% StemPros Neural Sup-
plement, 20 ng/ml FGFb and EGF and 2mM GlutaMAX™ (cells and culture reagents obtained from Thermo
Table 1
Primer sequences of NSC and neural lineage related genes.
Gene Symbol Forward primer Reverse primer RefSeq Ref
CD44 CD44 AGCAACTGAGACAGCAACCA AGACGTACCAGCCATTTGTGT NM_000610.3
Doublecortin Dcx TATGCGCCGAAGCAAGTCTC TACAGGTCCTTGTGCTTCCG NM_178152.2
Enolase 2 ENO2 TGCACAGGCCAGATCAAGAC ACAGCACACTGGGATTACGG NM_001975.2
Forkhead box A2 FOXA2 CTGGTCGTTTGTTGTGGCTG GGAGGAGTAGCCCTCGG NM_021784.4
Galactosylceramidase GalC GCCAAGCGTTACCATGATTT TTTCACTCGCTGGAGACCTT NM_001201402.1 [8]
Glial ﬁbrillary acidic protein GFAP GAGGTTGAGAGGGACAATCTGG GTGGCTTCATCTGCTTCCTGTC NM_002055.4
Human telomerase hTERT GACGTGGAAGATGAGCGTG GACGACGTACACACTCATC NM_001193376.1 NM_198253.2 [9]
Microtubule associated protein 2 MAP2 GACTGCAGCTCTGCCTTTAG AAGTAAATCTTCCTCCACTGTGAC NM_002374.3
Mushahi I MSI I TGACCAAGAGATCCAGGGGT CGATTGCGCCAGCACTTTAT NM_002442.3
Nanog homeobox NANOG ACCTCAGCTACAAACAGGTGAA AAAGGCTGGGGTAGGTAGGT NM_024865.2
Nestin NES CTCAGCTTTCAGGACCCCAA GTCTCAAGGGTAGCAGGCAA NM_006617.1
Neuroﬁlament M NEFM TGCAGTCCAAGAGCATCGAG GGATGGTGTCCTGGTAGCTG NM_005382.2
Neurogenin 2 NEUROG2 AGAGCCAACTAAGATGTTCGTCA CGATCCGAGCAGCACTAACA NM_024019.3
Oligodendrocyte transcription factor 1 OLIG1 GTCATCCTGCCCTACTCAGC CTGCCCAGCAGTAGGATGTAG NM_138983.2 [8]
Oligodendrocyte transcription factor 2 OLIG2 GACAAGCTAGGAGGCAGTGG CGGCTCTGTCATTTGCTTCT NM_005806.3 [8]
POU Class 5 homeobox 1 (OCT3/4) OCT3/4 ATCTTCAGGAGATATGCAAAGCAGA TGATCTGCTGCAGTGTGGGT NM_002701.4
SRY box 1 SOX1 CAACCAGGACCGGGTCAAAC CCTCGGACATGACCTTCCAC NM_005986.2
SRY box 2 SOX2 CCACCTACAGCATGTCCTACTCG GGGAGGAAGAGGTAACCACAGG NM_003106.3 [10]
S100 Calcium binding protein B S100B TTCTGGAAGGGAGGGAGACA CTCCTGCTCTTTGATTTCCTCT NM_006272.2
Vimentin VIM GGACCAGCTAACCAACGACAAA CGCATTGTCAACATCCTGTCTG NM_003380.3
βIII tubulin TUBB3 GGCCAAGTTCTGGGAAGTCAT CTCGAGGCACGTACTTGTGA NM_06086.3
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Table 2
Primer sequences of proteoglycan associated genes.
Gene Symbol Forward primer Reverse primer RefSeq Ref
Aggrecan AGG TGCATTCCACGAAGCTAACCTT CGCCTCGCCTTCTTGAAATGT NM_001135
C5-Epimerase C5-EP AGCTGTCAAGCCAACCAAAATAA CTTACTAGCCAATCACTAGCAGCAA AY635582
carbohydrate (chondroitin 6) sulfotransferase 3 CHST3 GGTTTTTGTGGTGATAGTTTTTGTCTT GCTGGGTCGGTGCTGTTG NM_004273
carbohydrate (chondroitin 4) sulfotransferase 11 CHST11 CTGCTGGAAGTGATGAGGATGA GATGTCCACACCAAAGGGATTC NM_018413
Decorin DCN TCCTGATGACCGCGACTT GAGTTGTGTCAGGGGGAAGA NM_001920.3
Exostose 1 EXT1 TGACAGAGACAACACCGAGTATGA GCAAAGCCTCCAGGAATCTGAAG NM_000127.2
Exostose 2 EXT2 CAGTCAATTAAAGCCATTGCCCTG GGGATCAGCGGGAGGAAGAG NM_000401
Glypican 1 GPC1 GGACATCACCAAGCCGGACAT GTCCACGTCGTTGCCGTTGT NM_002081
Glypican 2 GPC2 TGATCAGCCCCAACAGAGAAA CCACTTCCAACTTCCTTCAAACC NM_152742
Glypican 3 GPC3 GATACAGCCAAAAGGCAGCAA GCCCTTCATTTTCAGCTCATG NM_004484.
Glypican 4 GPC4 GGTGAACTCCCAGTACCACTTTACA GCTTCAGCTGCTCCGTATACTTG NM_001448
Glypican 5 GPC5 GCTCACCTCAATGGACAAAAATT GTTGGCAAGCGTCTCTTCACT NM_004466
Glypican 6 GPC6 CAGCCTGTGTTAAGCTGAGGTTT GATGTGTGTGCGTGGAGGTATGT NM_005708.
Heparanase HPSE TCACCATTGACGCCAACCT CTTTGCAGAACCCAGGAGGAT NM_006665.5
Heparan sulphate 2-O sulfotransferase 1 HS2ST1 TCCCGCTCGAAGCTAGAAAG CGAGGGCCATCCATTGTATG NM_012262
Heparan sulphate 6-O sulfotransferase 1 HS6ST1 AGCGGACGTTCAACCTCAAGT GCGTAGTCGTACAGCTGCATGT NM_004807
Heparan sulphate 6-O sulfotransferase 2 HS6ST2 TCTGGAAAGTGCCAAGTCAAATC ATGGCGAAATAAAGTTCATGTTGAA NM_147175
Heparan sulphate 6-O sulfotransferase 3 HS6ST3 ACATCACGCGGGCTTCTAACGT GGCGGTCCCTCTGGTGCTCTA NM_153456
N-deacetylase/N-sulfotransferase 1 NDST1 TGGTCTTGGATGGCAAACTG CGCCAAGGTTTTGTGGTAGTC NM_001543
N-deacetylase/N-sulfotransferase 2 NDST2 CCTATTTGAAAAAAGTGCCACCTACT GCAGGGTTGGTGAGCACTGT NM_003635
N-deacetylase/N-sulfotransferase 3 NDST3 ACCCTTCAGACCGAGCATACTC CCCGGGACCAAACATCTCTT NM_004784
N-deacetylase/N-sulfotransferase 4 NDST4 ATAAAGCCAATGAGAACAGCTTACC GGTAATATGCAGCAAAGGAGATTGA NM_022569
Perlecan PER TGGACACATTCGTACCTTTCTGA CCTCGGACACCTCTCGAAACT NM_005529
Syndecan 1 SDC1 CTGGGCTGGAATCAGGAATATTT CCCATTGGATTAAGTAGAGTTTTGC BC008765.2
Syndecan 2 SDC2 AGCTGACAACATCTCGACCACTT GCGTCGTGGTTTCCACTTTT NM_002998.3
Syndecan 3 SDC3 CTTGGTCACACTGCTCATCTATCG GCATAGAACTCCTCCTGCTTGTC AF248634
Syndecan 4 SDC4 CCACGTTTCTAGAGGCGTCACT CTGTCCAACAGATGGACATGCT BC030805.1
Versican VCN TGGAATGATGTTCCCTGCAA AAGGTCTTGGCATTTTCTACAACAG NM_004385.4
L.E.O
ikari
et
al./
D
ata
in
Brief
7
(2016)
206
–215
209
Fig. 1. Q-PCR analysis of pluripotency, NSC self-renewal, neuronal and glial lineage marker genes in hNSC H9 cells and nhNPCs.
Relative expression in hNSC H9 cells and nhNPCs of: (A) pluripotency markers; (B) NSC self-renewal markers; (C) neuronal
lineage deﬁning markers; and (D) glial lineage deﬁning markers. Relative expression normalised to 18 S, error bars¼SD, sta-
tistical signiﬁcance: n po0.05, nn po0.01, nnn po0.001.
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Fig. 2. Phenotypic and IF examination of NSC and neural lineage markers in hNSC H9 cells and nhNPCs. Phase-contrast
images (20 magniﬁcation with 10 magniﬁcation inset, scale bar 130 μM) of: (A) hNSC H9 cells at P3 and (B) nhNPCs
attached to surface (CC2 chamber slide) during expansion. Immunoﬂuorescence (20 magniﬁcation, scale bar 130 μM) in
hNSC H9 P3 cells and nhNPCs of stemness and lineage markers: (C) NSC self-renewal markers Nestin (FITC/green) and SOX2
(Cy3/yellow); and (D) neuronal marker MAP2 (FITC/green), astrocyte marker GFAP (Cy3/yellow) and oligodendrocyte marker
O1 (AF594/red).
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Table 3
Antibodies used for immunoﬂuorescence.
Primary antibodies Dilution Company (Cat)
Anti-Nestin (Mouse IgG) 1:200 Abcam (ab22035)
Anti-SOX2 (Rabbit IgG) 1:1000 Millipore (2003600)
Anti-MAP2 (Mouse IgG) 1:200 Abcam (ab36447)
Anti-GFAP (Rabbit IgG) 1:250 Abcam (ab7260)
Anti-O1 (Mouse IgM) 1:500 Abcam (ab34164)
Isotype Controls Dilution Company (Cat)
Mouse IgG 1:250 Millipore (PP54-100UG)
Rabbit IgG 1:250 Millipore (PP64-100UG)
Mouse IgM 1:500 Millipore (2003599)
Secondary antibodies Dilution Company (Cat)
Donkey Anti-Mouse IgG (FITC,
green)
1:250 Millipore (AP192F)
Donkey Anti-Rabbit (HþL) (Cy3,
yellow)
1:250 Millipore (AP182C)
Donkey Anti-Mouse IgM (Alexa-
Fluor 594, red)
1:500 Jackson Immunoresearch (715-
585-020)
L.E. Oikari et al. / Data in Brief 7 (2016) 206–215212Fisher). hNSC H9 cells were cultured in p35 (10 cm2) dishes with culture medium changed every two days
and cells passaged at 90% conﬂuence using TrypLE. hNSC H9 cells were passaged twice and harvested for
RNA at passage 3 (P3). Normal Human Neural Progenitor Cells (nhNPCs) isolated from the human brain
cortex were cultured as neurospheres in Neural Progenitor Maintenance Bulletkit™ medium (NPMM)
containing 200 mL of Neural Progenitor Basal Medium supplemented with 0.4 mL rhFGF-B, 0.4 mL rhEGF,
4 mL Neural Survival Factor-1 and 0.4 mL Gentamicin/Amphotericin (cells and culture reagents obtained
from Lonza). nhNPC neurosphere cultures were established by defrosting the cell ampule according to the
manufacturer’s instructions and dividing the cells into two T75 (75 cm2) ﬂasks containing 20 mL of NPMM.
hNSC H9 and nhNPCs cultures were maintained in 5% CO2 at 37 °C in a humidiﬁed atmosphere with
phenotype of the cells monitored under an Olympus IX81 inverted phase-contrast microscope.
2.2. RNA extraction
RNA was harvested from cultured cells using TRIzols reagent (Invitrogen) using the Direct-zol™
RNA miniprep kit (Zymo Research) according to the manufacturer’s instructions with samples treated
in-column with DNase I (Zymo Research). RNA was eluted in RNase-free H2O and concentration and
quality of RNA determined with a NanoDrop spectrophotometer (Thermo Scientiﬁc).
2.3. cDNA synthesis
For conversion of RNA into cDNA, 150 ng of RNA was incubated with 200 ng of Random Primer
(New England BioLabs) at 65 °C for 10 min in a reaction made up to 20 μl with Milli-Q-H2O. Samples
were then incubated with 10 U of Transcriptor Reverse Transcriptase (Roche) and 1 mM dNTPs (New
England Biolabs), 20 U of RNaseOUT (Invitrogen) in 1x RT reaction buffer in a total reaction volume of
30 μl. For the reverse transcription reaction samples were incubated at 25 °C for 10 min, then at 55 °C
for 30 min and ﬁnally at 85 °C for 5 min. Concentration and quality of cDNA was measured on a
NanoDrop spectrophotometer and cDNA was diluted to 40 ng/mL working concentrations.
2.4. Quantitative real-time PCR
Relative gene expression was detected using quantitative real-time PCR (Q-PCR). The 10 μl reac-
tion volume contained 5 μl of SYBRs-Green PCR Master Mix (Promega), 200 ng of forward and
reverse primer, 0.1 μl CXR reference dye (Promega) and 120 ng cDNA template. Ampliﬁcation was
monitored on an Applied Biosystems 7900HT Fast Real-Time PCR systemwith an enzyme activation of
2 min at 50 °C and 3 min at 95 °C followed by 50 cycles of 3 s at 95 °C and 30 s at 60 °C. The cycle
Fig. 3. Q-PCR analysis of proteoglycan biosynthesis enzyme gene expression in hNSC H9 cells and nhNPCs. Relative expression
in hNSC H9 cells and nhNPCs of: (A) HS chain synthesising and modifying enzymes; (B) HS chain N-deacelylating/N-sulfating
enzymes; (C) HS chain sulfating enzymes; and (D) CS chain sulfating enzymes. Relative expression normalised to 18 S, error
bars¼SD, statistical signiﬁcance: n po0.05, nn po0.01, nnn po0.001.
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TTCGAGGCCCTGTAATTGGA, reverse primer GCA GCAACTTAATATACGCTAT) Ct values (ΔCt value)
included in each run, and relative gene expression was determined by the ΔΔCt value (2(ΔCt)). For
ease of graphic presentation of relative gene expression, ΔΔCt values were multiplied by 106. Primer
sequences for detected NSC and neural lineage genes are presented in Table 1 and primer sequences
for heparan and chondroitin sulphate proteoglycan associated genes are presented in Table 2.
2.4.1. Immunoﬂuorescence (IF)
Expression of selected NSC and neural lineage marker proteins were detected via IF using an Olympus
IX81 inverted phase-contrast ﬂuorescent microscope and images acquired using Volocity software (Perkin-
Elmer) on a Hamamatsu Orca camera. For imaging, cells were plated on 8-well CC2-coated chamber slides
(Lab-Tek) at 20–30104 cells/well and cells were cultured for 3–4 days before ﬁxing and staining. Brieﬂy,
Fig. 4. Q-PCR analysis of proteoglycan core protein gene expression in hNSC H9 cells and nhNPCs. Relative expression in hNSC H9 cells
and nhNPCs of: cell surface HSPGs (A) syndecans; (B) glypicans; and extracellular CSPGs and HSPGs (C) aggrecan, versican, perlecan
and decorin. Relative expression normalised to 18 S, error bars¼SD, statistical signiﬁcance: n po0.05, nn po0.01, nnn po0.001.
L.E. Oikari et al. / Data in Brief 7 (2016) 206–215214culture medium was removed, cells rinsed with 1 PBS with Ca2þ and Mg2þ and ﬁxed with 4% paraf-
ormaldehyde. After this cells were blocked (5% Donkey serum, 1% BSA in PBS with or without 0.1% Triton-X
to allow permeabilisation) and primary antibodies were incubated overnight at 4 °C. Isotype control anti-
bodies were used as a negative control. After 24 h incubation, primary antibodies were removed, cells
rinsed with 1 PBS with Ca2þ and Mg2þ and cells incubated with secondary antibodies for 2 h at room
temperature. Finally, cells were rinsed with 1 PBS with Ca2þ and Mg2þ and slides mounted with DAPI
(ab104139, Abcam). Antibodies and dilutions used are presented in Table 3.2.4.2. Statistical analysis
For Q-PCR analysis each gene was detected in quadruplicate per sample. Paired t-test was used to
determine statistical signiﬁcance and deﬁned as * po0.5, ** po0.01 and *** po0.001. Error bars
represent SD.
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